2:15 PM - 2:30 PM (EDT), Tuesday, June 6, 2023 ・ Session Room 104A
Redwire is at the forefront of biological and physical-science research in space. It has developed more than a dozen payloads – four of which currently are operating on the International Space Station. The company's key products include the 3D BioFabrication Facility: the first American system capable of manufacturing human tissue in microgravity; the Multi-use Variable-gravity Platform: containing a set of centrifuges for in-space biological and physical-science research; the Advanced Space Experiment Processor: a multipurpose device for biological research and small scale manufacturing in space; and the Bone Densitometer: an in-orbit X-ray machine chiefly used by Redwire customers for researching new treatments for osteoporosis and muscle wasting diseases.

Redwire's development pipeline includes a new payload for 3D printing metal and electronic components, and devices for manufacturing pharmaceuticals and large quantities of human cells for bioprinting and cell therapies.
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
Company HQ Country:
United States
Year Founded:
Not Provided
Main Therapeutic Focus:
Tools/Drug Development Support Tech
Lead Product in Development:
Not Provided
Development Phase of Primary Product:
Multiple Products in Market
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided